4//SEC Filing
Inbar Galia 4
Accession 0001209191-22-014470
CIK 0000818686other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:48 AM ET
Size
7.6 KB
Accession
0001209191-22-014470
Insider Transaction Report
Form 4
Inbar Galia
See "Remarks"
Transactions
- Exercise/Conversion
Restricted Share Units
2022-02-28−4,828→ 9,657 total→ Ordinary Shares (4,828 underlying) - Exercise/Conversion
Ordinary Shares
2022-02-28+4,828→ 9,656 total
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on February 28, 2020, with 4,828 having vested on each of February 28, 2021 and February 28, 2022, 4,828 vesting on February 28, 2023 and 4,829 vesting on February 28, 2024.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001878086
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 7:48 AM ET
- Size
- 7.6 KB